Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring. Canadian Diabetes & Endocrinology Today, [S. l.], v. 4, n. 1, p. 10–16, 2026. DOI: 10.58931/cdet.2026.4150. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-1-Kissock. Acesso em: 26 may. 2026.